Patricia L Kannouche

10PUBLICATIONS
111CO-AUTHORS
Reaction engineering (excl. nuclear reactions)Molecular targetsPredictive and prognostic markersHaematological tumoursCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 04, 2025
Patritumab deruxtecan in HR+HER2- advanced breast cancer: a phase 2 trial.

Barbara Pistilli, Fernanda Mosele, Noemie Corcos

|Oct 22, 2024
Metabolic Tumor Volume Assessed by 18F FDG-PET CT Scan as a Predictive Biomarker for Immune Checkpoint Blockers in Advanced NSCLC and Its Biological Correlates.

Filippo G Dall'Olio, Wael Zrafi, Veronique Roelants

|Sep 04, 2023
In vivo reduction of RAD51-mediated homologous recombination triggers aging but impairs oncogenesis.

Gabriel Matos-Rodrigues, Vilma Barroca, Ali-Akbar Muhammad

|Jul 24, 2023
Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trial.

Fernanda Mosele, Elise Deluche, Amelie Lusque

|May 04, 2023
Genomic mutation landscape of skin cancers from DNA repair-deficient xeroderma pigmentosum patients.

Andrey A Yurchenko, Fatemeh Rajabi, Tirzah Braz-Petta

Pageof 2